Representative FACS profiles. Data are represented as mean ± SEM (n=5, C; n=3, E, F). p >0.1, *, p <0.05, **, p <0.01, ***, p <0.0001. (Figure 2A ) is a triple transgenic strain (R26YFP-CXCR4 fl/fl -Vav CRE ), which carries the BM tagged with the YFP and that is homozygote for the deletion of the CXCR4 gene. It has been generated by crossing the homozygous CXCR4 fl/fl with the double heterozygote R26YFP-Vav CRE . Triple transgenic mice were PCR selected and used in this study. The BM YFP/CXCR4-/-transgenic mice were exclusively used to assess BMCs trafficking in presence or not of CXCR4. In contrast, for liver regeneration and proliferation experiments we used the double transgenic strain BM CXCR4-/-described below.
BM
CXCR4-/-( Figure 2C ) is a double transgenic strain (CXCR4 fl/fl -Vav CRE ) with the homozygote deletion of the CXCR4 gene in the BM. It has been generated by crossing the homozygous CXCR4 fl/fl with the homozygous Vav CRE strain. Double transgenic mice were PCR selected and used in this study.
R26Y-BM RFP/CRE chimeric mice ( Figure 3A ) were generated by replacing the BM of transgenic mice carrying the Rosa26-LoxP-stop-LoxP-YFP allele with the BM of donor mice expressing the CRE under the pan hematopoietic specific promoter VAV and expressing the RFP under CAG ubiquitous promoter.
Alb
CRE -BM R26Y chimeric mice ( Figure 4A ) were generated by replacing the BM of transgenic mice carrying the Albumin-CRE allele (the liver specific promoter Albumin controlling Cre) with the BM of donor mice carrying the Rosa26-LoxP-stop-LoxP-YFP allele.
R26DTR-BM
RFP/CRE chimeric mice ( Figure 5A ) were generated by replacing the BM of transgenic mice carrying the Rosa26-LoxP-stop-LoxP-DTR allele (DTR; dipheria toxin receptor) with the BM of donor mice expressing the CRE under the hematopoietic specific promoter VAV and expressing the RFP under CAG ubiquitous promoter. R26DTR-BM Alb/CRE chimeric mice ( Figure 5G ) were generated by replacing the BM of transgenic mice carrying the Rosa26-LoxP-stop-LoxP-DTR allele (DTR; dipheria toxin receptor) with the BM of donor mice expressing the CRE under the liver specific promoter Albumin.
Irradiation and Bone Marrow transplant
Recipient mice were total body irradiated with 9 Gy (double dose of 4,5 Gy) in a lucite chamber, six weeks before surgery and/or drugs treatment. Donor BM was obtained from the long bones of young mice between 9-12 weeks old by gently flushing their femurs with phosphate-buffered saline (PBS). Cells were centrifuged, resuspended and counted in a hemocytometer. From 10 5 to 10 7 cells in 0.1 ml were intravenously injected into recipient mice 24h after irradiation. Surgery 70% and 30% liver resection were carried out as previously reported in (Mitchell and Willenbring, 2008) and (Mitchell et al., 2005) .
Liver Cell and Hybrid purification
Primary mouse hepatocytes were isolated by the two-step liver perfusion method. The liver was firstly perfused with the Hepatocyte Liver Perfusion Medium (1x) (Gibco) and then with the Hepatocyte Liver Digest Medium (1x) (Gibco) until liver lobes felt very soft. Subsequently to liver digestion, the perfused lobes were transferred to a Petri dish containing 10 ml of Hepatocyte Liver Perfusion Medium and mechanically disrupted. The cell suspension was forced through a 100 µm Cell Strainer (BD) into a 50 ml Falcon tube and centrifuged at 135 g for 30 seconds. The cell suspension was fractionated in Percoll gradient Centrifugation at 750g during 20min (without brake). The upper layer, enriched for non-parenchymal cells (NPCs) was separated by the lower layer containing parenchymal cells (PCs), which include hepatocytes and hybrids. The NPC fraction contains however also hematopoietic cells (HCs) and it was either analysed by FACS to measure cell fusion between HCs and NPCs, or further processed for the purification of nucleated HCs. Finally, purified HCs and PCs were mixed and analysed by FACS to measure both BMC recruitment and cell fusion.
Cell Fraction Type of Experiment

PCs=Hepatocytes and Hybrids Cell Cycle analysis (Ki67)
PCs mixed to HCs BMC recruitment and/or Cell fusion analysis
NPCs not separated from HCs Cell fusion analysis
Schematic of flow cytometry and cell sorting protocol
Mice were euthanized with CO 2 and perfused with phosphate-buffered saline (PBS) until the liver lobes drained off the blood and appeared pale. Liver samples were collected and cells were purified by a double disaggregation step as previously described. For BMC recruitment and cell fusion, purified PCs and HCs were mixed before the analysis ( Figures 1D, 2B , 3B left plot, 3C, 4C, 4F, 4G, 5B, 5C, 7G, S1D, S2A, S3C, S4C and S5A), whereas for proliferation (Ki67 staining) purified PCs were analysed alone ( Figures 7C, 7D , S1C, S2D, S2E, S5D, S5E and S5H), with the exception of Figure 3F where Ki67 staining was performed on the mixture of purified PCs and HCs to asses the proliferation potential of BMCs (RFP+/YFP-) and hybrids (RFP+/YFP+) simultaneously. Finally, to test cell fusion of BMCs with NPCs, the NPC fraction was directly analysed without processing the sample for HCs purification ( Figure 3B 
Intracellular staining
For intracellular staining cells were fixed with Cytofix/Cytoperm Plus kit from BD (Cat.554715), following manufacturer instructions, before being incubated with specific antibodies. In case of indirect staining, fluorescent conjugated secondary antibodies were used for antigens detection, working concentration 1:1000. The antibody used were: FITC Mouse anti-Ki67 from the "BD Pharmigen FITC Mouse Anti-Human Ki67 Set" following manufacturer instructions (Cat:556026); Anti-RFP (Abcam; ab62341), working concentration 1:300; anti-HNF-4a (Santa Cruz C-19; sc-6556), working concentration 1:300; anti-GFP eFluor 660, clone 5F12.4 (eBioscience), working concentration 1:100.
Histology and immunohistochemical staining.
Mice were euthanized with CO 2 and perfused with phosphate-buffered saline (PBS) until the liver lobes drained off the blood and appeared pale. For paraffin histology, liver was fixed in 10% neutral buffered formalin for 48h. Representative sections were trimmed, processed, embedded in paraffin, blocked, sectioned, and stained with H&E or with the appropriate antibody for immunohistochemistry. Stained slides were examined microscopically unbiased by 2 board-certified pathologists (S.A.Y., A.d.B). The primary antibodies used were: anti-GFP, clone B-2 (Santa Cruz sc-9996), working concentration 1:500; and Ki67 (Thermo scientific at 1:75). Secondary antibody was diluted 1:1000. VECTASTAIN Elite ABC Kit (Vector Laboratories) and DAB Peroxidase Substrate (Vector Laboratories) were used for detection. For Ki67 staining, sections were deparaffinized and rehydrated to water, then rinsed in 1xTBS for 10 minutes. Sections were microwaved in 10mM citrate Buffer for 5 minutes at 40% power in an 1100W oven and left to cool on benchtop for 20 minutes. After a 10 minute wash in 1x TBS, endogenous peroxidase activity was blocked with 0.5% H 2 O 2 in 1x TBS for 10 minutes. 10% NGS was applied for 1 hour and then Ki67 (Thermo scientific at 1:75), antibody were applied overnight. Positive and negative control sections were performed for every antibody. In negative control sections, the primary antibody was omitted and replaced by PBS. Sections were washed, incubated for 1 hour in biotinylated anti-rabbit secondary diluted in 1% BSA in TBS (Vector Labs BA-1000 at 1:200) and then 30 minutes with Vectastain Elite ABC reagent. Sections were washed and then incubated in DAB substrate kit for 4 minutes (Vector SK 4100). Sections were counterstained in hematoxylin, dehydrated and coverslipped. For quantification of Ki67-positive hepatocytes in 5 random x20 fields, image processing tools in ImageJ software (US National Institutes of Health, Bethesda, Md., USA; http://rsb.info.nih. gov/ij/) were used. In brief, representative images were taken from 5 random x20 fields from every liver using Olympus DP25 camera mounted on Olympus BX45 microscope. The images were converted to a binary signal and ki67-positive hepatocytes were counted by using the particle analysis nucleus counter plugin for ImageJ software.
Immunofluorescence
Paraffin sections, obtained as described in the previous section, were deparaffinised, blocked with PBS 0,3% triton 10% Monkey serum and incubated over night with anti GFP chicken (ABCAM, Ab 13970), working concentration 1:500; anti-HNF-4a (Santa Cruz C-19; sc-6556), working concentration 1:500; anti-C-Kit (Santa Cruz H-300; sc-5535), working concentration 1:500; anti-CRE recombinase (Millipore, 2D8; MAB3120), working concentration 1:200. Upon incubation with the primary antibody, sections were washed twice with PBS 0,3% Triton and incubated for 2 hours at room temperature with the appropriate fluorescent conjugated antibody diluted 1:1000.
Drug treatment
To block BMC migration, mice received 6 intraperitoneal injections of the CXCR4 antagonist AMD3100 (1 mg/Kg, Sigma A5602), starting 3 days before surgery. For selective ablation of in vivo formed hybrids, Diphtheria Toxin from Corynebacterium diphtheria (sigma D0564) was intraperitoneally injected (200ng) during 5 days, starting 2 days before surgery.
In vitro cell fusion
For in vitro cell fusion, 1.0 X 10 6 hepatocytes, purified from healthy and in vivo damaged liver after 70% hepatectomy, were co-cultured with 1.0 X 10 6 HSPCs purified from healthy donor mice and depleted of the lineage positive fraction, using the Lineage Cell Depletion Kit from Miltenyi Biotec (130-090-858). The linege-positive fraction was also fused. Hepatocytes and HSPCs or Lin+ (ratio 1:1) were maintained 4h in Hematopoietic growth media plus cytokines (StemSpan SFEM from STEMCELL Technologies supplemented with Flt3, IL-1, IL-6 and SCF). Cells were then collected, pelleted and resuspended in PBS with 2% FCS with DAPI for FACS analysis. Cells were labelled with DiD (Hepatocytes) and DiO (HSPCs and Lin+ cells) (Vybrant Multicolor Cell-Labeling from Life technologies) respectively before being co-cultured. qPCR For quantitative PCR, the total RNA was extracted from mESCs using the RNeasy kit (Qiagen), and the cDNA was generated from 1 µg of RNA using Superscript III (Invitrogen). For cDNA 25 ng was used as template for each reaction, in a 10 µl reaction volume. LightCycler 480 SYBR Green I Master (Roche) was used with LightCycler ® 480 System (Roche). The primers used were:
Mathematical model derivation (implicit hybrids)
While in the rat model proliferation starts soon after hepatectomy (Furchtgott et al., 2009) , our data in mouse suggest that it is delayed (Figures S1C, 2E and 5F), as also previously reported (Weglarz and Sandgren, 2000) . To account for this, a delay (!) was introduced between the Q and the P states ( Figure S1A ). Our data suggest also an additional delay (θ) between the P and the R states ( Figure  S1A ): in the toxin treated mice, no substantial regeneration is observed between 24h and 72h ( Figure  5D , days 1-3), despite a significant appearance of Ki67 positive cells ( Figure 5F, days 1-3 ). Similarly to (Furchtgott et al., 2009 ), in our model both BMC recruitment and cell proliferation are an inverse function of the liver mass, in such a way that these two processes are triggered upon resection, and terminate when the regeneration process is completed. The new parameter k rec determines the speed of the recruitment process. Attempts to fit the experimental data have suggested that it is necessary for most BMCs to arrive early in the regeneration process. Since BMCs also proliferate after they are recruited, it was not possible to determine whether this is actually the case in situ, so we left it as a model prediction. By raising the term 1/N to the power α (Figure S1A ), the recruitment curve is accentuated early in the regeneration. Regarding the molecular equations, as in (Furchtgott et al., 2009) , the cytokines pathway is responsible for triggering the immediate-early gene response, which primes liver cells to respond to growth factors. Growth factors are responsible for cell-cycle progression, which leads to hepatocyte replication. The extra-cellular matrix, in addition to capturing growth factors (hence inhibiting proliferation indirectly), is also directly responsible for the requiescence of the replicating cells. Of note, in the reference model (Furchtgott et al., 2009) , tumor necrosis factor (TNF) and growth factor (GF) were produced proportionally to the metabolic load per cell M/N, with M being a parameter, and N the total liver mass. To maintain the original dynamics of the pathway underlying regeneration, we considered the metabolic load in the molecular equations not dependent on BMCs. All parameters of this model (fitting details reported below) are included in Table S1 .
Extended model derivation (explicit hybrids)
To explicitly account for hybrids, we inserted in the model an extra variable (H in Figure S6A ); its rate is modelled to be proportional to the amount of BMC and Quiescent cells not already fused, and proportional to a constant (k fus ), which indicates the fusion efficiency. Hybrids and BMCs are assumed to participate to the reversible transition of cells from the Q to the P state (see first and second equations in Figure S6A ). The total liver cell mass (N) in the cellular equations is now given by the sum of Quiescent, Primed, Replicating, BM and Hybrid cells; as in the original model (implicit hybrids), the metabolic load in the molecular equations is assumed to depend on hepatocytes only. Molecular equations and related parameters are kept identical to the original model. Fitted parameters of the hybrids extended model are reported in Table S2 .
Extended model derivation (hypertrophy)
To investigate whether taking into account hypertrophy would change our modelling results, we used the approach proposed in (Cook et al., 2015) and extended it using the features we proposed in the main text. This version of the model ( Figure S6B) contains an equation for G (as in Cook et al., 2015) , which is initially set to 1, that is a function of the total liver mass N; G boosts the relative cell mass of primed and replicating cells. As our original model without hybrids, the extended model with hyperthrophy also includes the time delays ! and θ and the formalism for BMC recruitment. Fitted parameters of the hyperthropy extended model are reported in Table S3 .
Mathematical model fitting and simulations
The experimental data used for fitting include regeneration data (N = Q + P + R in the original model, N=Q+P+R+B+H in the hybrids extended model, N = Q + G(P + R) in the hypertrophy extended model) and proliferation (P + R) under wild type and impaired conditions. The mass of intact liver was normalized to 1, as in (Furchtgott et al., 2009) . Two types of impairment data were fitted, CXCR4 receptor knock-out 7 days after hepatectomy ( Figures 2C and S2D ) and toxin treatment ( Figures 5D  and S5D ) for the original and hybrids model, while only the CXCR4 receptor knock-out data was fitted using the hyperthropy model. Also, AMD3100 treated/untreated regeneration data-sets ( Figure 1B) were fitted (original model). To take into account differences in the genetic background of the mice used for the toxin, CXCR4 knock-out and AMD3100 experiments, fitting was performed separately for the wild type control animals in all conditions. The fitting was done manually, while all model simulations were performed using Mathematica (Wolfram Research, Inc., Mathematica, Version 9.0, Champaign, IL 2012). The first step was to fit the parameters that describe BMC dynamics (k rec and α), taking advantage of data of regeneration at 24h in wild type control strains (accordingly to the data, the regeneration dynamics of the first 24h are given entirely by BMC recruitment). Parameters in molecular interactions underlying liver regeneration ( Figure S1B ), in the original and hybrids model, were kept to the values estimated in (Furchtgott et al., 2009) , with the exception of parameters k 1 to k 7, which were re-calculated in order to ensure that growth factors and cytokines, which are triggered upon injury, are at constant values in case of no resection (steady state in equations in Figure S1B ). Remaining parameters were also fixed to the values in the reference paper, besides k Q , k P , k R , k prol and k req and the new k rec , α, ! and θ. These are all contained in the first part of the model (cellular equations, Figures S1A, S6A and S6B) . Notably, a similar approach was used to fit the model against data from human (Periwal et al., 2014) . For simulating the cases of complete gene ablation and toxin intervention, the approach we used was to "exaggerate" the parameter changes from the wild type conditions in the original model (Table S1 ) by using the observed reduction in BMCs and hybrids as a measurement of the in situ efficacy of each intervention. Parameter values were estimated based on the observation that the levels of BMCs and hybrids are approximately halved in each experiment ( Figures 2B and 5B) . Hence, when the estimated parameter value increased in the experimental impairment versus control (Table S1 ), the impaired value was doubled; when it decreased, was halved. Of note, while in the receptor case impairment becomes visible immediately, in the toxin case it becomes visible only after the beginning of proliferation; this is because hybrids are accounted for implicitly in the model. However, the simulation should be regarded as reliable once proliferation starts. When fitting the hypertrophy model, we found that the resulting wild type system was more sensitive to changes in parameters; hence, in fitting the impairment condition, smaller fold-changes in parameter values were required. However, because we started from the model of Cook et al. and extended it, we opted to use the values they suggested for all constants; in some cases (e.g., metabolic load), the values were different from the ones we used in our own work. Hence, in addition to the structural changes to the model, moving it to a new region in the parameter space can also explain the observed increase in parameter sensitivity. When fitting experimental data for 30% hepatectomy (control mice used in toxin experiments), it was readily apparent from the data that recruitment dynamics change with the level of hepatectomy, with stronger recruitment taking place than in the 70% case, as well as recruitment not starting immediately after surgery (compare data in Figure 5C with BMC data-green dots-in Figure 7A ). Thus, to fit the 30% data, we delayed the beginning of recruitment and adjusted the value of k rec (Table S1 ). In predicting the regeneration dynamics of BM CXCR4fl/fl mice upon 30% hepatectomy ( Figure 7B ), the experimental data required to choose a value different from the toxin case for the delay in the BMC recruitment, probably because the delay is specie dependant. The value of k rec was adjusted relatively to the 70% one in the same ratio as in the mouse used for the toxin case.
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